Simoctocog alfa for haemophilia A: No suitable data

(Institute for Quality and Efficiency in Health Care) No added benefit can be derived from the dossier: The duration of the direct comparative studies was too short and the study pool on one-arm studies with the comparator therapy was incomplete.

Source: EurekAlert! - Medicine and Health - February 20, 2015 Category: Global & Universal Source Type: news